Guggenheim reiterates Merck stock rating on oncology pipeline

Guggenheim reiterates Merck stock rating on oncology pipeline  Investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.